Deuterated (Trifluoromethyl)pyrimidine 2 Amine Compounds As

Deuterated (Trifluoromethyl)pyrimidine 2 Amine Compounds As Potentiators Of The Hmrgx1 Receptor

Abstract: The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof, useful for treating pain, including chronic pain, chronic lower back pain, diabetic peripheral neuropathic pain, and osteoarthritis pain.

Patent Information

Application #

Filing Date

08 May 2024

Publication Number

49/2024

Publication Type

INA

Invention Field

BIO-CHEMISTRY

Status

Email

Parent Application

Applicants

ELI LILLY AND COMPANY

LILLY CORPORATE CENTER Indianapolis, Indiana 46285

Inventors

1. RUBLE, James Craig

c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288

2. WINNEROSKI, Leonard Larry

c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288

Specification

Documents

Application Documents

#	Name	Date
1	202417036374-STATEMENT OF UNDERTAKING (FORM 3) [08-05-2024(online)].pdf	2024-05-08
2	202417036374-REQUEST FOR EXAMINATION (FORM-18) [08-05-2024(online)].pdf	2024-05-08
3	202417036374-PRIORITY DOCUMENTS [08-05-2024(online)].pdf	2024-05-08
4	202417036374-POWER OF AUTHORITY [08-05-2024(online)].pdf	2024-05-08
5	202417036374-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [08-05-2024(online)].pdf	2024-05-08
6	202417036374-FORM 18 [08-05-2024(online)].pdf	2024-05-08
7	202417036374-FORM 1 [08-05-2024(online)].pdf	2024-05-08
8	202417036374-FIGURE OF ABSTRACT [08-05-2024(online)].pdf	2024-05-08
9	202417036374-DECLARATION OF INVENTORSHIP (FORM 5) [08-05-2024(online)].pdf	2024-05-08
10	202417036374-COMPLETE SPECIFICATION [08-05-2024(online)].pdf	2024-05-08
11	202417036374-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [08-05-2024(online)].pdf	2024-05-08
12	202417036374-FORM 3 [16-08-2024(online)].pdf	2024-08-16
13	202417036374-Proof of Right [18-10-2024(online)].pdf	2024-10-18